Impact of statins on depression and suicidality: a systematic review

Statins have been proposed for repurposing in depression, but previous meta-analyses reported heterogeneous results and seldom addressed suicidality. We systematically reviewed the association of statin treatment with the risk of depression, depressive symptom severity and suicidality. We searched 3 databases (Embase, PsycINFO and PubMed) up to 31 March 2026 for observational and interventional studies in predominantly adult populations, published in English or French. Risk of bias and methodological quality were assessed with RoB 2 for randomised controlled trials (RCTs) and the NIH/NHLBI tools for observational studies. Results were synthesised by design, outcome and sample size. Sixty studies were included (9 cross-sectional, 38 longitudinal and 13 RCTs; 20 to over 4.6 million participants), 55 assessing depression and 11 suicidality. Observational associations were heterogeneous: generally modest in large general-population studies, mainly inverse in disease-specific populations, but discordant after stroke and traumatic brain injury. Larger antidepressant effects of adjunctive statins were reported in small single-centre RCTs. In contrast, the two largest trials in major depressive disorder, both at low risk of bias, yielded estimates close to zero. No consistent association with suicidality was observed, and no trial showed a significant worsening of mood. This systematic review updates and extends previous meta-analyses on statins. Observational results were heterogeneous. Lower suicide mortality was observed in two cohorts, but the largest study found no association with suicidal behaviour. Larger antidepressant effects were confined to small single-centre trials. Current evidence therefore does not support prescribing statins for antidepressant or suicide-preventive purposes.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-19
DOI
https://doi.org/10.21203/rs.3.rs-11767079/v1
Primary Topic
Treatment of Major Depression
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Impact of statins on depression and suicidality: a systematic review

Nicolas Hoertel, Louis Colin, Ariel Frajerman, Tarsis Carvalo Ouro Vitorino Silva1
Research Square
Treatment of Major Depression
preprint

Impact of statins on depression and suicidality: a systematic review

Nicolas Hoertel, Louis Colin, Ariel Frajerman, Tarsis Carvalo Ouro Vitorino Silva1
preprint en

Abstract

Statins have been proposed for repurposing in depression, but previous meta-analyses reported heterogeneous results and seldom addressed suicidality. We systematically reviewed the association of statin treatment with the risk of depression, depressive symptom severity and suicidality. We searched 3 databases (Embase, PsycINFO and PubMed) up to 31 March 2026 for observational and interventional studies in predominantly adult populations, published in English or French. Risk of bias and methodological quality were assessed with RoB 2 for randomised controlled trials (RCTs) and the NIH/NHLBI tools for observational studies. Results were synthesised by design, outcome and sample size. Sixty studies were included (9 cross-sectional, 38 longitudinal and 13 RCTs; 20 to over 4.6 million participants), 55 assessing depression and 11 suicidality. Observational associations were heterogeneous: generally modest in large general-population studies, mainly inverse in disease-specific populations, but discordant after stroke and traumatic brain injury. Larger antidepressant effects of adjunctive statins were reported in small single-centre RCTs. In contrast, the two largest trials in major depressive disorder, both at low risk of bias, yielded estimates close to zero. No consistent association with suicidality was observed, and no trial showed a significant worsening of mood. This systematic review updates and extends previous meta-analyses on statins. Observational results were heterogeneous. Lower suicide mortality was observed in two cohorts, but the largest study found no association with suicidal behaviour. Larger antidepressant effects were confined to small single-centre trials. Current evidence therefore does not support prescribing statins for antidepressant or suicide-preventive purposes.

Research Square
Université Paris Cité (FR), Université Paris-Saclay (FR), FHU Neurovasc (FR)
Treatment of Major Depression
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon